share_log
Moomoo 24/7 ·  Apr 11 08:02
MEI Pharma Inc: to Prioritize Clinical Development of Voruciclib While Enabling Development of a New Me-344 Formulation for Phase 1 Study
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment